**Core Concept**
The question is testing the student's knowledge of short-acting beta-2 agonists, a class of medications used to treat bronchospasm and asthma. These medications work by stimulating beta-2 receptors in the lungs, causing bronchodilation and relaxation of smooth muscle.

**Why the Correct Answer is Right**
Short-acting beta-2 agonists, such as salbutamol (also known as albuterol), work by binding to beta-2 adrenergic receptors in the lungs. This binding causes an increase in intracellular cAMP, leading to relaxation of bronchial smooth muscle and bronchodilation. The effects of short-acting beta-2 agonists are rapid, with peak effects occurring within 5-15 minutes, and the duration of action is approximately 4-6 hours.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a short-acting beta-2 agonist. Long-acting beta-2 agonists, such as salmeterol, have a longer duration of action (12-24 hours) and are used as maintenance therapy in asthma.
**Option B:** This option is incorrect because it does not specify a beta-2 agonist. Beta-1 agonists, such as dobutamine, primarily stimulate the heart and are used to treat heart failure.
**Option C:** This option is incorrect because it does not specify a beta-2 agonist. Beta-3 agonists, such as mirabegron, primarily stimulate the bladder and are used to treat overactive bladder.

**Clinical Pearl / High-Yield Fact**
Short-acting beta-2 agonists, such as salbutamol, are the first-line treatment for acute asthma symptoms and are often used as rescue medication. However, they should not be used as maintenance therapy due to the risk of tolerance and worsening symptoms.

**Correct Answer:** D. Salbutamol